These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4345217)

  • 21. The response of children to a reduced dose of measles vaccine given with and without other vaccines. (pilot study).
    Cruickshank JG; Dalton H; Lochrie G; Campbell I
    Cent Afr J Med; 1974 Oct; 20(10):201-2. PubMed ID: 4426084
    [No Abstract]   [Full Text] [Related]  

  • 22. [Viral vaccines and local immunity].
    Norrby E
    Lakartidningen; 1979 Oct; 76(40):3404-7. PubMed ID: 502677
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccine requirements of college students.
    Blake PA
    J Am Coll Health Assoc; 1972 Dec; 21(2):131-3. PubMed ID: 4641386
    [No Abstract]   [Full Text] [Related]  

  • 24. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current problems of vaccination].
    Grahneis H
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):510-6. PubMed ID: 4398882
    [No Abstract]   [Full Text] [Related]  

  • 26. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination against infectious laryngotracheitis of chickens: determination of immunity following eyedrop or spray vaccination using serology and challenge infections].
    Redmann T; Buken B; Kaleta EF; Lüders H; Siegmann O
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):137-41. PubMed ID: 6305625
    [No Abstract]   [Full Text] [Related]  

  • 28. Keeping immunizations up to date.
    Reece RM
    Am Fam Physician; 1974 Mar; 9(3):119-25. PubMed ID: 4855929
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of immunizing agents in pregnancy.
    Med Lett Drugs Ther; 1970 Mar; 12(5):23-4. PubMed ID: 5506731
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mixed vaccinations].
    Labusquière R
    Bull Int Union Tuberc; 1973 Dec; 48 Suppl():55-7. PubMed ID: 4803722
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
    Lu X; Edwards LE; Desheva JA; Nguyen DC; Rekstin A; Stephenson I; Szretter K; Cox NJ; Rudenko LG; Klimov A; Katz JM
    Vaccine; 2006 Nov; 24(44-46):6588-93. PubMed ID: 17030078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the sensitivity of the body to heterologous viral infections following immunization with different virus vaccines. I. The ability of live polio vaccine and tick-borne encephalitis vaccine to evoke resistance to heterologous viral infections].
    Gorshunova LP; Nabokova AV
    Br J Soc Clin Psychol; 1970 Dec; 9(4):83-6. PubMed ID: 5494794
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinology and selected virus diseases.
    Dull HB
    Adv Intern Med; 1971; 17():143-70. PubMed ID: 4950244
    [No Abstract]   [Full Text] [Related]  

  • 35. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New recommendations for simultaneous administration of live virus vaccines.
    Reeve AM
    J Iowa Med Soc; 1973 Feb; 63(2):50 passim. PubMed ID: 4687453
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
    Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.